Carl Zeiss Meditec AG

Earnings Release • Sep 16, 2002

News Details

Ad-hoc | 16 September 2002 07:37

Carl Zeiss Meditec AG english

Quarterly figures within expectations Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Quarterly figures within expectations Q3 turnover increases by 5.1 percent — Elimination of risks at former Asclepion has one-off effect on results In the first nine months of the 2001/2002 financial year (1 October 2001 to 30 June 2002) Carl Zeiss Meditec AG achieved pro forma sales revenues of EUR 172.4 million (previous year: EUR 173.6 million). The operating result (EBIT) in this period amounted to EUR -4.9 million (EUR 2.6 million), biased by the one-off elimination of risk items at the former Asclepion. In the third quarter the Jena-based company posted a 5.1% increase in sales to EUR 57.6 million. Due to the one-time financial burden, the pro forma result before taxes (EBT) totalled EUR -12.5 million (previous year: EUR 1.6 million). The after-tax result amounted to EUR -7.6 million (previous year: EUR 1.5 million). This corresponds to a pro forma loss per share of EUR 0.29 (previous year: EUR 0.06). The result reflects a EUR 15.1 million one-off adjustment for all foreseeable risks. This figure includes a valuation adjustment on inventories (EUR 2.6 million) and accounts receivable (EUR 3.8 million), amortisation of goodwill of the British subsidiary (EUR 3.4 million) not affecting liquidity and depreciation of financial assets of the former Asclepion (EUR 5.3 million). The pro forma figures serve to facilitate comparison with the previous year. The latter is based on the premise that the new company already existed at the start of the financial year on 1 October 2000, although the two companies Asclepion-Meditec and Carl Zeiss Ophthalmic Systems were not merged into Carl Zeiss Meditec until 4 July 2002. Contact: Carl Zeiss Meditec AG Jens Brajer/ Investor Relations Göschwitzer Strasse 51-52 07745 Jena Phone: +49 (0) 36 41 – 2 20 – 1 05 Fax: +49 (0) 36 41 – 2 20 – 1 02 E-mail: investors@meditec.zeiss.com end of ad-hoc-announcement (c)DGAP 16.09.2002 ——————————————————————————– WKN: 531370; ISIN: DE0005313704; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München und Stuttgart 160737 Sep 02